Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Mirum Pharmaceuticals, Inc. | 194,309 | reported | 16 Mar 2026 | tx 68+1,900,339−617,293 |
| Regado Biosciences Inc | 0 | reported | 01 Nov 2016 | tx 8+285,823−285,823 |
| Nivalis Therapeutics, Inc. | 0 | reported | 20 May 2024 | tx 17+71,900−70,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 Mar 2026 | EXERCISE | Mirum Pharmaceuticals, Inc. | 25,000 | — | |
| 15 Mar 2026 | EXERCISE | Mirum Pharmaceuticals, Inc. | 50,000 | — | |
| 16 Mar 2026 | SALE | Mirum Pharmaceuticals, Inc. | 40,985 | 91.98 USD | |
| 15 Mar 2026 | EXERCISE | Mirum Pharmaceuticals, Inc. | 25,000 | 0.00 USD | deriv |
| 15 Mar 2026 | EXERCISE | Mirum Pharmaceuticals, Inc. | 50,000 | 0.00 USD | deriv |
| 02 Feb 2026 | SALE | Mirum Pharmaceuticals, Inc. | 9,108 | 103.30 USD | |
| 28 Jan 2026 | GRANT_AWARD | Mirum Pharmaceuticals, Inc. | 75,000 | 0.00 USD | deriv |
| 28 Jan 2026 | GRANT_AWARD | Mirum Pharmaceuticals, Inc. | 43,500 | 0.00 USD | deriv |
| 28 Jan 2026 | GRANT_AWARD | Mirum Pharmaceuticals, Inc. | 67,000 | 0.00 USD | deriv |
| 23 Jan 2026 | EXERCISE | Mirum Pharmaceuticals, Inc. | 12,500 | — | |
| 26 Jan 2026 | SALE | Mirum Pharmaceuticals, Inc. | 6,831 | 96.19 USD | |
| 23 Jan 2026 | EXERCISE | Mirum Pharmaceuticals, Inc. | 12,500 | 0.00 USD | deriv |
| 21 Jan 2026 | EXERCISE | Mirum Pharmaceuticals, Inc. | 12,797 | — | |
| 22 Jan 2026 | SALE | Mirum Pharmaceuticals, Inc. | 7,098 | 93.33 USD | |
| 21 Jan 2026 | EXERCISE | Mirum Pharmaceuticals, Inc. | 12,797 | 0.00 USD | deriv |
| 31 Dec 2025 | GIFT | Mirum Pharmaceuticals, Inc. | 21,070 | 0.00 USD | |
| 18 Nov 2025 | EXERCISE | Mirum Pharmaceuticals, Inc. | 19,133 | 19.24 USD | |
| 18 Nov 2025 | EXERCISE | Mirum Pharmaceuticals, Inc. | 19,133 | 0.00 USD | deriv |
| 11 Aug 2025 | SALE | Mirum Pharmaceuticals, Inc. | 40,000 | 62.00 USD | |
| 11 Aug 2025 | EXERCISE | Mirum Pharmaceuticals, Inc. | 40,000 | 2.94 USD | |
| 11 Aug 2025 | EXERCISE | Mirum Pharmaceuticals, Inc. | 40,000 | 0.00 USD | deriv |
| 07 Aug 2025 | SALE | Mirum Pharmaceuticals, Inc. | 40,000 | 55.25 USD | |
| 07 Aug 2025 | EXERCISE | Mirum Pharmaceuticals, Inc. | 40,000 | 2.94 USD | |
| 07 Aug 2025 | EXERCISE | Mirum Pharmaceuticals, Inc. | 40,000 | 0.00 USD | deriv |
| 15 Mar 2025 | EXERCISE | Mirum Pharmaceuticals, Inc. | 50,000 | — |
1 purchase reported after at least 12 months of silence — most recent on 23 Dec 2020.